A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL

Clinical trial NCT05026229 · UNKNOWN

Trial details

NCT number: NCT05026229
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Precursor Cell Lymphoblastic Leukemia-Lymphoma Philadelphia-Positive Acute Lymphoblastic Leukemia ALL, Adult

Start date: 2021-09-06
Primary completion: 2023-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.